PharmiWeb1h
Candid Health Raises $52.5 Million Series C to Enhance GenAI Features, Expand Revenue Cycle Automation Platform to More Providers
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Candid Health, the autonomous revenue cycle automation platform for healthcare providers, today announced it has raised $52.5 million ...
PharmiWeb4h
Healthcare Analytics Market Size/Growth 2025-2035
Market OverviewThe Global Healthcare Analytics Market is valued at $33.80 Billion in the year 2022 and is forecasted to reach ...
PharmiWeb4h
Generic Drugs Market 2024-2035: Trends, Innovations, and Future Growth
Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...
PharmiWeb4h
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
PharmiWeb4h
Precision Medicine Market Analysis & Forecast 2025-2035
Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...
PharmiWeb4h
Seaport Therapeutics Announces the Publication of…
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...
PharmiWeb4h
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...
PharmiWeb6h
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the ...
PharmiWeb6h
CTT Pharma Gives Update On NSF Grant
TAMPA, FL / ACCESS Newswire / February 12, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) submitted a full proposal to the National Science Foundation(NSF) for our patented fast dissolving ...
PharmiWeb7h
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica ...
PharmiWeb8h
Biolog Purchases Anaerobe Systems, Its Third Acquisition, Becoming the Knowledge Leader in Microbiology Research and Clinical Sample Prep
HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, ...
PharmiWeb9h
BIMZELX[®] (bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in hidradenitis suppurativa (HS)
UCB, a global biopharmaceutical company, today announced long-term data from the BE HEARD^ trials for BIMZELX®▼ (bimekizumab) in moderate to severe hidradenitis suppurativa (HS). These two-year data, ...